FDA approves Artoss’ NanoBone SBX Putty

Foley, Minn.-based biotech Artoss recently earned market clearance from the Food and Drug Administration for NanoBone SBX Putty.

Advertisement

NanoBone SBX Putty is a synthetic bone replacement material intended to stimulate quicker bone formation, according to the NanoBone’s website.

Artoss plans to introduce the product to the U.S. market in the next few weeks.

More articles on supply chain:

5 trends on the growing role of digitization in supply chain
FDA approves expanded use of Janssen’s Darzalex for multiple myeloma patients
Texas Blood Center in desperate need of O-negative blood

 

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.